Molina Healthcare (MOH) grants 317-share quarterly award to director

Rhea-AI Filing Summary

Molina Healthcare, Inc. reported a routine equity grant to one of its directors. On January 1, 2026, the director received 317 shares of Molina common stock under the company’s 2025 Equity Incentive Plan as compensation for board service. The grant represents one quarterly portion of an annual equity award valued at $220,000, with this quarter’s installment set at $55,000.

The number of shares was calculated using the closing price of Molina’s common stock of $173.54 on December 31, 2025, because the grant date was a non‑trading day. Following this grant, the director beneficially owns 5,176 shares of Molina Healthcare common stock, held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BRASIER BARBARA L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	317	$173.54	$55K

Holdings After Transaction: Common Stock — 5,176 shares (Direct)

Footnotes (1)

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock. Represents the closing price of the Issuer's common stock on December 31, 2025.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRASIER BARBARA L

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/01/2026		A(1)		317(2)	A	$173.54(3)	5,176	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

3. Represents the closing price of the Issuer's common stock on December 31, 2025.

Remarks:

	Jeff D. Barlow, by power of attorney for Barbara L. Brasier	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Molina Healthcare (MOH) report in this Form 4?

Molina Healthcare reported that one of its directors received a grant of 317 shares of common stock on January 1, 2026 as part of director compensation.

How is the director equity compensation structured for Molina Healthcare (MOH)?

The filing states that each director’s annual equity award has an aggregate dollar value of $220,000, with $55,000 granted on the first day of each quarter under the 2025 Equity Incentive Plan.

How was the number of Molina Healthcare (MOH) shares in this grant calculated?

Because January 1, 2026 was a non‑trading day, the 317 shares were determined using the closing price of Molina common stock of $173.54 on December 31, 2025, to match the quarterly award value of $55,000.

What is the director’s total beneficial ownership of Molina Healthcare (MOH) stock after this transaction?

After the reported grant, the director beneficially owns 5,176 shares of Molina Healthcare common stock, held in direct ownership.

Is this Molina Healthcare (MOH) Form 4 transaction a purchase or a grant?

The transaction is described as a grant of stock under Molina Healthcare’s 2025 Equity Incentive Plan, provided in connection with the director’s services on the board.

What plan governs this Molina Healthcare (MOH) director stock grant?

The stock grant was made under the company’s 2025 Equity Incentive Plan, as explained in the “Explanation of Responses” section of the filing.